Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
2(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
25%
Ph phase_2
1
13%
Ph not_applicable
4
50%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
2(28.6%)
N/ANon-phased studies
4(57.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(5)
Terminated(1)

Detailed Status

Completed5
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (14.3%)
Phase 32 (28.6%)
N/A4 (57.1%)

Trials by Status

completed563%
recruiting225%
withdrawn113%

Recent Activity

2 active trials
Showing 5 of 8
completednot_applicable

Spinal Interneuron Excitability in ALS

NCT02429492
completednot_applicable

Evaluation of the Impact of Lesions of the Motor and Proprioceptive Brain and Pan-medullary Pathways on Their Clinically and Electrophysiologically Assessed Function in Multiple Sclerosis

NCT04220814
recruitingnot_applicable

Objectively Diagnose and Monitor Treatment of Light Sensitivity

NCT03694626
withdrawnphase_2

Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility Study

NCT00449085
recruitingnot_applicable

The preSPG4 Study - Studying the Prodromal and Early Phase of SPG4

NCT03206190
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT02429492Not Applicable

Spinal Interneuron Excitability in ALS

Completed
NCT04220814Not Applicable

Evaluation of the Impact of Lesions of the Motor and Proprioceptive Brain and Pan-medullary Pathways on Their Clinically and Electrophysiologically Assessed Function in Multiple Sclerosis

Completed
NCT03694626Not Applicable

Objectively Diagnose and Monitor Treatment of Light Sensitivity

Recruiting
NCT00449085Phase 2

Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility Study

Withdrawn
NCT03206190Not Applicable

The preSPG4 Study - Studying the Prodromal and Early Phase of SPG4

Recruiting
NCT00000480Phase 3

Multicenter Unsustained Tachycardia Trial (MUSTT)

Completed
NCT00000518Phase 3

Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)

Completed
NCT01361828

Optic Nerve and Retinal Functions With Bevacizumab

Completed

All 8 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
8